Illumina pays $9.8 million to settle DOJ claims over cybersecurity failures in government contracts

Illumina Inc., a major biotechnology firm based in San Diego, has agreed to pay $9.8 million to settle allegations brought by the U.S. Department of Justice that it sold genomic sequencing systems to federal agencies despite known cybersecurity vulnerabilities.